Skip to main content
SpringerLink
Log in

Bildgebende Verfahren bei der Diagnose des Prostatakarzinoms

Imaging procedures to diagnose prostate cancer

  • CME Weiterbildung • Zertifizierte Fortbildung
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Das Prostatakarzinom ist eine der häufigsten malignen Erkrankungen des Mannes. Trotz ständiger Fortschritte bei den bildgebenden Verfahren gilt die Prostatastanzbiopsie als Goldstandard bei der Diagnostik des Prostatakarzinoms. Auch bei der Beurteilung des Lymphknotenstatus gibt ausschließlich die Staginglymphadenektomie eine valide Auskunft. Ziel dieser Arbeit ist die Beleuchtung der in Deutschland zur Verfügung stehenden bildgebenden Verfahren mit ihrem Stellenwert beim Primär- und Lymphknotenstaging sowie beim biochemischen Rezidiv.

Abstract

Prostate cancer is one of the most frequent malignant diseases in men. Despite constant progress achieved in imaging procedures, prostate biopsy is the gold standard for diagnosing prostate cancer. For the assessment of lymph node status, only staging lymphadenectomy provides valid information. The aim of this work is to analyze the imaging procedures available in Germany and their value in primary and lymph node staging as well as biochemical recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8

Literatur

  1. Watanabe H, Igari D, Tanahasi Y et al. (1974) Development and application of new equipment for transrectal ultrasonography. J Clin Ultrasound 2: 91–98

    Article  PubMed  CAS  Google Scholar 

  2. McNeal JE (1981) The zonal anatomy of the prostate. Prostate 2: 35–49

    Article  PubMed  CAS  Google Scholar 

  3. Rifkin MD, Dahnert W, Kurtz AB (1990) State of the art: endorectal sonography of the prostate gland. Am J Roentgenol 154: 691–700

    CAS  Google Scholar 

  4. Sedelaar JP, Vijverberg PL, De Reijke TM et al. (2001) Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives. Eur Urol 40: 275–284

    Article  PubMed  CAS  Google Scholar 

  5. Cornud F, Belin X, Piron D et al. (1997) Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 49: 709–715

    Article  PubMed  CAS  Google Scholar 

  6. Halpern EJ, Strup SE (2000) Using gray-scale and color and power Doppler sonography to detect prostatic cancer. Am J Roentgenol 174: 623–627

    CAS  Google Scholar 

  7. Song JM, Kim CB, Chung HC, Kane RL (2005) Prostate-specific antigen, digital rectal examination and transrectal ultrasonography: a meta-analysis for this diagnostic triad of prostate cancer in symptomatic korean men. Yonsei Med J 46: 414–424

    Article  PubMed  Google Scholar 

  8. Kuligowska E, Barish MA, Fenlon HM, Blake M (2001) Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers. Radiology 220: 757–764

    Article  PubMed  CAS  Google Scholar 

  9. Rifkin MD, Alexander AA, Helinek TG, Merton DA (1991) Color Doppler as an adjunct to prostate ultrasound. Scand J Urol Nephrol Suppl 137: 85–89

    PubMed  CAS  Google Scholar 

  10. Sauvain JL, Palascak P, Bourscheid D et al. (2003) Value of power doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer. Eur Urol 44: 21–30; discussion 30–31

    Article  PubMed  CAS  Google Scholar 

  11. Ismail M, Petersen RO, Alexander AA et al. (1997) Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival. Urology 50: 906–912

    Article  PubMed  CAS  Google Scholar 

  12. Kelly IM, Lees WR, Rickards D (1993) Prostate cancer and the role of color Doppler US. Radiology 189: 153–156

    PubMed  CAS  Google Scholar 

  13. Newman JS, Bree RL, Rubin JM (1995) Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 195: 86–90

    PubMed  CAS  Google Scholar 

  14. Cho JY, Kim SH, Lee SE (1998) Diffuse prostatic lesions: role of color Doppler and power Doppler ultrasonography. J Ultrasound Med 17: 283–287

    PubMed  CAS  Google Scholar 

  15. Cho JY, Kim SH, Lee SE (2000) Peripheral hypoechoic lesions of the prostate: evaluation with color and power Doppler ultrasound. Eur Urol 37: 443–448

    Article  PubMed  CAS  Google Scholar 

  16. Sakarya ME, Arslan H, Unal O et al. (1998) The role of power Doppler ultrasonography in the diagnosis of prostate cancer: a preliminary study. Br J Urol 82: 386–388

    PubMed  CAS  Google Scholar 

  17. Remzi M, Dobrovits M, Reissigl A et al. (2004) Can power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy? Eur Urol 46: 451–456

    PubMed  Google Scholar 

  18. Cho IR, Keener TS, Nghiem HV et al. (2000) Prostate blood flow characteristics in the chronic prostatitis/pelvic pain syndrome. J Urol 163: 1130–1133

    Article  PubMed  CAS  Google Scholar 

  19. Rifkin MD, Sudakoff GS, Alexander AA (1993) Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 186: 509–513

    PubMed  CAS  Google Scholar 

  20. Tong S, Cardinal HN, McLoughlin RF et al. (1998) Intra- and inter-observer variability and reliability of prostate volume measurement via two-dimensional and three-dimensional ultrasound imaging. Ultrasound Med Biol 24: 673–681

    Article  PubMed  CAS  Google Scholar 

  21. Garg S, Fortling B, Chadwick D et al. (1999) Staging of prostate cancer using 3-dimensional transrectal ultrasound images: a pilot study. J Urol 162: 1318–1321

    Article  PubMed  CAS  Google Scholar 

  22. Hamper UM, Trapanotto V, DeJong MR et al. (1999) Three-dimensional US of the prostate: early experience. Radiology 212: 719–723

    PubMed  CAS  Google Scholar 

  23. Mehta SS, Azzouzi AR, Hamdy FC (2004) Three dimensional ultrasound and prostate cancer. World J Urol 22: 339–345

    Article  PubMed  CAS  Google Scholar 

  24. Sedelaar JP, Roermund JG van, Leenders GL van et al. (2001) Three-dimensional grayscale ultrasound: evaluation of prostate cancer compared with benign prostatic hyperplasia. Urology 57: 914–920

    Article  PubMed  CAS  Google Scholar 

  25. Strasser H, Frauscher F, Klausser A et al. (2003) Three-dimensional transrectal ultrasound in staging of localised prostate cancer. J Urology 169: 299A

    Google Scholar 

  26. Bogers HA, Sedelaar JP, Beerlage HP et al. (1999) Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 54: 97–104

    Article  PubMed  CAS  Google Scholar 

  27. Halpern EJ, Rosenberg M, Gomella LG (2001) Prostate cancer: contrast-enhanced us for detection. Radiology 219: 219–225

    PubMed  CAS  Google Scholar 

  28. Frauscher F, Klauser A, Volgger H et al. (2002) Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 167: 1648–1652

    Article  PubMed  Google Scholar 

  29. Halpern EJ, Ramey JR, Strup SE et al. (2005) Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer 104: 2373–2383

    Article  PubMed  Google Scholar 

  30. Amiel GE, Slawin KM (2006) Newer modalities of ultrasound imaging and treatment of the prostate. Urol Clin North Am 33: 329–337

    Article  PubMed  Google Scholar 

  31. Pepe P, Patane D, Panella P, Aragona F (2003) Does the adjunct of ecographic contrast medium Levovist improve the detection rate of prostate cancer? Prostate Cancer Prostatic Dis 6: 159–162

    Article  PubMed  CAS  Google Scholar 

  32. Hardeman SW, Causey JQ, Hickey DP, Soloway MS (1989) Transrectal ultrasound for staging prior to radical prostatectomy. Urology 34: 175–180

    Article  PubMed  CAS  Google Scholar 

  33. Rorvik J, Halvorsen OJ, Servoll E, Haukaas S (1994) Transrectal ultrasonography to assess local extent of prostatic cancer before radical prostatectomy. Br J Urol 73: 65–69

    PubMed  CAS  Google Scholar 

  34. Bates TS, Gillatt DA, Cavanagh PM, Speakman M (1997) A comparison of endorectal magnetic resonance imaging and transrectal ultrasonography in the local staging of prostate cancer with histopathological correlation. Br J Urol 79: 927–932

    PubMed  CAS  Google Scholar 

  35. Colombo T, Schips L, Augustin H et al. (1999) Value of transrectal ultrasound in preoperative staging of prostate cancer. Minerva Urol Nefrol 51: 1–4

    PubMed  CAS  Google Scholar 

  36. Ozgur A, Onol FF, Turkeri LN (2004) Important preoperative prognostic factors for extracapsular extension, seminal vesicle invasion and lymph node involvement in cases with radical retropubic prostatectomy. Int Urol Nephrol 36: 369–373

    Article  PubMed  CAS  Google Scholar 

  37. Anagnostou T, Doumas K, Remzi M, Djavan B (2004) Postradical prostatectomy TRUS-guided anastomotic biopsy. Where do we stand today? Prostate Cancer Prostatic Dis 7: 302–310

    Article  PubMed  CAS  Google Scholar 

  38. Drudi FM, Giovagnorio F, Carbone A et al. (2006) Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy – comparison with MRI. Ultraschall Med 27: 146–151

    Article  PubMed  CAS  Google Scholar 

  39. Tamsel S, Killi R, Apaydin E et al. (2006) The potential value of power Doppler ultrasound imaging compared with grey-scale ultrasound findings in the diagnosis of local recurrence after radical prostatectomy. Clin Radiol 61: 325–330; discussion 323–324

    Article  PubMed  CAS  Google Scholar 

  40. Schlemmer HP, Merkle J, Grobholz R et al. (2004) Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol 14: 309–317

    Article  PubMed  Google Scholar 

  41. Seitz M, Scher B, Graser A et al. (2006) Advances in metabolic imaging in patients with elevated prostate specific antigen. EAU-EBU Update Series 4: 20–32

    Google Scholar 

  42. Mueller-Lisse UG, Vigneron DB, Hricak H et al. (2001) Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. Radiology 221: 380–390

    Article  PubMed  CAS  Google Scholar 

  43. Villers A, Puech P, Leroy X et al. (2007) Dynamic contrast-enhanced MRI for preoperative identification of localized prostate cancer. Eur Urol Suppl 6: 525–532

    Article  Google Scholar 

  44. Engelbrecht MR, Jager GJ, Laheij RJ et al. (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12: 2294–2302

    PubMed  Google Scholar 

  45. Heuck A, Scheidler J, Sommer B et al. (2003) MR imaging of prostate cancer. Radiologe 43: 464–473

    Article  PubMed  CAS  Google Scholar 

  46. Scheidler J, Hricak H, Vigneron DB et al. (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging – clinicopathologic study. Radiology 213: 473–480

    PubMed  CAS  Google Scholar 

  47. Graser A, Heuck A, Sommer B et al. (2007) Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology. Am J Roentgenol 188: 84–90

    Article  Google Scholar 

  48. Amsellem-Ouazana D, Younes P, Conquy S et al. (2005) Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 47: 582–586

    Article  PubMed  Google Scholar 

  49. Yuen JS, Thng CH, Tan PH et al. (2004) Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 171: 1482–1486

    Article  PubMed  CAS  Google Scholar 

  50. Anastasiadis AG, Lichy MP, Nagele U et al. (2006) MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50: 738–748; discussion 748–749

    Article  PubMed  CAS  Google Scholar 

  51. Aus G, Abbou CC, Bolla M et al. (2005) EAU guidelines on prostate cancer. Eur Urol 48: 546–551

    Article  PubMed  CAS  Google Scholar 

  52. Sella T, Schwartz LH, Swindle PW et al. (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231: 379–385

    Article  PubMed  Google Scholar 

  53. Reske SN, Kotzerke J (2001) FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, „Onko-PET III“, 21 July and 19 September 2000. Eur J Nucl Med 28: 1707–1723

    Article  PubMed  CAS  Google Scholar 

  54. Agus DB, Golde DW, Sgouros G et al. (1998) Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal. Cancer Res 58: 3009–3014

    PubMed  CAS  Google Scholar 

  55. Effert PJ, Bares R, Handt S et al. (1996) Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J Urol 155: 994–998

    Article  PubMed  CAS  Google Scholar 

  56. Oyama N, Akino H, Kanamaru H et al. (2002) 11C-acetate PET imaging of prostate cancer. J Nucl Med 43: 181–186

    PubMed  CAS  Google Scholar 

  57. Seltzer MA, Barbaric Z, Belldegrun A et al. (1999) Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer. J Urol 162: 1322–1328

    Article  PubMed  CAS  Google Scholar 

  58. Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM (2001) Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 61: 3599–3603

    PubMed  CAS  Google Scholar 

  59. Breeuwsma AJ, Pruim J, Jongen MM et al. (2005) In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer. Eur J Nucl Med Mol Imaging 32: 668–673

    Article  PubMed  Google Scholar 

  60. Hara T, Kosaka N, Kishi H (1998) PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 39: 990–995

    PubMed  CAS  Google Scholar 

  61. Coleman R, DeGrado T, Wang S et al. (2000) Preliminary evaluation of F-18 Fluorocholine (FCH) as a PET tumor imaging agent. Clin Positron Imaging 3: 147

    Article  PubMed  Google Scholar 

  62. DeGrado TR, Coleman RE, Wang S et al. (2001) Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res 61: 110–117

    PubMed  CAS  Google Scholar 

  63. Hara T, Kosaka N, Kishi H (2002) Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med 43: 187–199

    PubMed  CAS  Google Scholar 

  64. Oyama N, Miller TR, Dehdashti F et al. (2003) 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med 44: 549–555

    PubMed  CAS  Google Scholar 

  65. Kotzerke J, Volkmer BG, Glatting G et al. (2003) Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer. Nuklearmedizin 42: 25–30

    PubMed  CAS  Google Scholar 

  66. Larson SM, Morris M, Gunther I et al. (2004) Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer. J Nucl Med 45: 366–373

    PubMed  CAS  Google Scholar 

  67. Toth G, Lengyel Z, Balkay L et al. (2005) Detection of prostate cancer with 11C-methionine positron emission tomography. J Urol 173: 66–69; discussion 69

    Article  PubMed  Google Scholar 

  68. Yoshida S, Nakagomi K, Goto S et al. (2005) 11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging. Urol Int 74: 214–220

    Article  PubMed  CAS  Google Scholar 

  69. Jong IJ de, Pruim J, Elsinga PH et al. (2002) Visualization of prostate cancer with 11C-choline positron emission tomography. Eur Urol 42: 18–23

    Article  PubMed  Google Scholar 

  70. Yamaguchi T, Lee J, Uemura H et al. (2005) Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy. Eur J Nucl Med Mol Imaging 32: 742–748

    Article  PubMed  CAS  Google Scholar 

  71. Scher B, Seitz M, Albinger W et al. (2007) Value of (11)C-choline PET and PET/CT in patients with suspected prostate cancer. Eur J Nucl Med Mol Imaging 34: 45–53

    Article  PubMed  Google Scholar 

  72. Reske SN, Blumstein NM, Neumaier B et al. (2006) Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med 47: 1249–1254

    PubMed  CAS  Google Scholar 

  73. Jong IJ de, Pruim J, Elsinga PH et al. (2003) Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med 44: 331–335

    PubMed  Google Scholar 

  74. Kotzerke J, Prang J, Neumaier B et al. (2000) Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med 27: 1415–1419

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologische Klinik und Poliklinik, Klinikum der Universität München,Campus Großhadern,Ludwig-Maximilians-Universität München, Marchioninistraße 15, 81377, München, Deutschland

    M. Seitz, D. Tilki, B. Schlenker, C. Gratzke, P. Stanislaus, O. Reich & C. Stief

  2. Nuklearmedizinische Klinik und Poliklinik, Klinikum der Universität München, Campus Großhadern, Ludwig-Maximilians-Universität München, München, Deutschland

    B. Scher

  3. Institut für Diagnostische Radiologie, Klinikum der Universität München, Campus Großhadern, Ludwig-Maximilians-Universität München, München, Deutschland

    M. Scherr & U. Müller-Lisse

  4. Institut für Pathologie, Klinikum der Universität München, Campus Großhadern, Ludwig-Maximilians-Universität München, München, Deutschland

    A. Schipf

  5. Anatomisches Institut, Universitätsklinikum Essen, Essen, Deutschland

    D. Tilki

Authors
  1. M. Seitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Scher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Scherr
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Tilki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Schlenker
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Gratzke
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Schipf
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. Stanislaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. U. Müller-Lisse
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. O. Reich
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. C. Stief
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Seitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seitz, M., Scher, B., Scherr, M. et al. Bildgebende Verfahren bei der Diagnose des Prostatakarzinoms. Urologe 46, 1435–1448 (2007). https://doi.org/10.1007/s00120-007-1455-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-007-1455-x

Schlüsselwörter

Keywords

Search

Navigation